Sage Journals: Discover world-class research

Abstract

Objectives

Albuminuria and serum adiponectin levels are factors that have been associated with the development of cardiovascular disease in patients with diabetes mellitus. Here we investigated the relationship between serum adiponectin levels and aortic stiffness in nondialysis diabetic kidney disease patients with stage 3–5 chronic kidney disease.

Methods

Fasting blood samples were obtained from 80 nondialysis diabetic kidney disease patients with stage 3–5 chronic kidney disease. Carotid-femoral pulse wave velocity (cfPWV) was measured using applanation tonometry; cfPWV values of >10 m/s were defined as aortic stiffness. Serum adiponectin levels were determined by enzyme immunoassay.

Results

Forty-two patients (52.5%) with nondialysis diabetic kidney disease were diagnosed with aortic stiffness. The patients in this group were older (p = 0.011), had higher systolic blood pressure (p = 0.002) and urine albumin-to-creatinine ratios (p = 0.013), included fewer females (p = 0.024), and had lower serum adiponectin (p = 0.001) levels than those in the control group. Multivariable logistic regression analysis revealed that serum adiponectin was independently associated with aortic stiffness (odds ratio = 0.930, 95% confidence interval: 0.884–0.978, p = 0.005) and also positively correlated with cfPWV values by multivariable linear regression (β = –0.309, p = 0.002) in nondialysis diabetic kidney disease patients.

Conclusions

The results suggested that serum adiponectin levels could be used to predict aortic stiffness in nondialysis diabetic kidney disease patients with stage 3–5 chronic kidney disease.

Keywords

Adiponectin albuminuria aortic stiffness carotid-femoral pulse wave velocity diabetic kidney disease

Get full access to this article

View all access options for this article.

References

Chamberlain

Rhinehart

Shaefer

Jr , et al. Diagnosis and management of diabetes: synopsis of the 2016 American Diabetes Association standards of medical care in diabetes. Ann Intern Med 2016; 164: 542–552.

Roett

Liegl

Jabbarpour

Diabetic nephropathy – the family physician's role. Am Fam Physician 2012; 85: 883–889.

Mogensen

Christensen

Vittinghus

The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy. Diabetes 1983; 32: 64–78.

Adler

Stevens

Manley

, et al. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003; 63: 225–232.

Naka

Papathanassiou

Bechlioulis

, et al. Determinants of vascular function in patients with type 2 diabetes. Cardiovasc Diabetol 2012; 11: 127

Cavalcante

Lima

Redheuil

, et al. Aortic stiffness: current understanding and future directions. J Am Coll Cardiol 2011; 57: 1511–1522.

Safar

ME.

Pulse pressure in essential hypertension: clinical and therapeutical implications. J Hypertens 1989; 7: 769–776.

Mancia

Fagard

Narkiewicz

, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31: 1281–1357.

Herder

Carstensen

Ouwens

DM.

Anti-inflammatory cytokines and risk of type 2 diabetes. Diabetes Obes Metab 2013; 15: 39–50.

10.

Parida

Siddharth

Sharma

Adiponectin, obesity, and cancer: clash of the bigwigs in health and disease. Ijms 2019; 20: 2519

11.

Fang

Liu

Kim

, et al. Adiponectin attenuates angiotensin II-induced oxidative stress in renal tubular cells through AMPK and cAMP-Epac signal transduction pathways. Am J Physiol Renal Physiol 2013; 304: F1366–F1374.

12.

Windham

Griswold

Farasat

, et al. Influence of leptin, adiponectin, and resistin on the association between abdominal adiposity and arterial stiffness. Am J Hypertens 2010; 23: 501–507.

13.

Youn

Kim

Park

, et al. Adiponectin and progression of arterial stiffness in hypertensive patients. Int J Cardiol 2013; 163: 316–319.

14.

Chen

Hsu

Lee

, et al. High serum adipocyte fatty acid binding protein level as a potential biomarker of aortic arterial stiffness in hypertensive patients with metabolic syndrome. Clin Chim Acta 2017; 473: 166–172.

15.

Lee

, et al. Hypoadiponectinemia correlates with arterial stiffness in kidney transplantation patients. Clin Exp Nephrol 2015; 19: 534–541.

16.

Shih

Hsu

Hou

, et al. Association of low serum adiponectin levels with aortic arterial stiffness in patients with type 2 diabetes. Jcm 2019; 8: 887

17.

Hou

Wang

Lai

, et al. Negative correlation of serum adiponectin levels with carotid-femoral pulse wave velocity in patients treated with hemodialysis. Biol Res Nurs 2018; 20: 462–468.

18.

Sung

Chuang

Sheu

, et al. Relation of adiponectin and high-sensitivity C-reactive protein to pulse-wave velocity and N-terminal pro-B-type natriuretic peptide in the general population. Am J Cardiol 2009; 103: 1411–1416.

19.

Chertow

Fan

, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296–1305.

20.

Foley

Parfrey

Sarnak

MJ.

Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9: S16–23.

21.

Bian

Guo

, et al. Association of glomerular filtration rate with arterial stiffness in Chinese women with normal to mildly impaired renal function. J Geriatr Cardiol 2012; 9: 158–165.

22.

Smith

Tomlinson

Ford

, et al. Elastin degradation is associated with progressive aortic stiffening and all-cause mortality in predialysis chronic kidney disease. Hypertension 2012; 59: 973–978.

23.

Wang

Zhang

Telljohann

, et al. Chronic matrix metalloproteinase inhibition retards age-associated arterial proinflammation and increase in blood pressure. Hypertension 2012; 60: 459–466.

24.

Sun

Aging, arterial stiffness, and hypertension. Hypertension 2015; 65: 252–256.

25.

Mogensen

CE.

Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984; 310: 356–360.

26.

de Boer

Afkarian

Rue

, et al. Renal outcomes in patients with type 1 diabetes and macroalbuminuria. Jasn 2014; 25: 2342–2350.

27.

; Matsushita

van der Velde

Astor

, et al.; Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375: 2073–2081.

28.

Deckert

Feldt-Rasmussen

Borch-Johnsen

, et al. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989; 32: 219–226.

29.

Stehouwer

Henry

Dekker

, et al. Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: further evidence for a link between microalbuminuria and endothelial dysfunction–the Hoorn Study. Kidney Int Suppl 2004; 92: S42–S44.

30.

Lin

Tang

, et al. Gender difference in the relationship of albuminuria and arterial stiffness in Chinese adults - a 6.6-year follow-up longitudinal study. Kidney Blood Press Res 2018; 43: 1479–1487.

31.

Mulè

Cottone

Cusimano

, et al. The association of microalbuminuria with aortic stiffness is independent of C-reactive protein in essential hypertension. Am J Hypertens 2009; 22: 1041–1047.

32.

Liu

Tavintharan

Yeoh

, et al. High normal albuminuria is independently associated with aortic stiffness in patients with Type 2 diabetes. Diabet Med 2014; 31: 1199–1204.

33.

Frystyk

Tarnow

Hansen

, et al. Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications. Diabetologia 2005; 48: 1911–1918.

34.

Fujita

Morii

Koshimura

, et al. Possible relationship between adiponectin and renal tubular injury in diabetic nephropathy. Endocr J 2006; 53: 745–752.

35.

Christou

Kiortsis

DN.

The role of adiponectin in renal physiology and development of albuminuria. J Endocrinol 2014; 221: R49–R61.

36.

Altemtam

Russell

El Nahas

A study of the natural history of diabetic kidney disease (DKD). Nephrol Dial Transplant 2012; 27: 1847–1854.

37.

Trujillo

Scherer

PE.

Adipose tissue-derived factors: impact on health and disease. Endocr Rev 2006; 27: 762–778.

38.

Laughlin

Barrett-Connor

May

Sex-specific determinants of serum adiponectin in older adults: the role of endogenous sex hormones. Int J Obes (Obes) 2007; 31: 457–465.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.51 MB

Hypoadiponectinemia is associated with aortic stiffness in nondialysis diabetic patients with stage 3–5 chronic kidney disease